The Management Board of Selvita S.A. with its registered office in Krakow (“Issuer”) hereby announces that on December 23, 2021 the affiliated company of the Issuer – Fidelta d.o.o. with its registered offices in Zagreb, Croatia, (“Fidelta”), has received two purchase orders with a total value of EUR 2.288.450,00 (PLN 11.538.059,72 converted at the rate EUR 1 = PLN 4,6359) under a framework of a Master Service Agreement, entered into on the December 16th 2019 by Fidelta and the Client – a biotechnology company located in the U.S. (“Client”)

The scope of the orders includes chemistry collaboration in FTE model with ADME and PK Screening support over the next 12 months in the Client’s R&D projects.

Taking into account value of the purchase orders and continuation of the collaboration between the Client and Fidelta, the Issuer’s Management Board considers those purchase orders to be significant.

Legal basis: Art. 17.1 of MAR

Representatives of the Company:     

  • Bogusław Sieczkowski – President of the Management Board
  • Dawid Radziszewski – Management Board Member